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Acetaminophen (N-acetyl p-aminophenol or APAP) is used worldwide for its antipyretic and
anti-inﬂammatory potential. However, APAP overdose sometimes causes severe liver damage.
In this study, we elucidated the protective effects of carveol in liver injury, using molecular and in
silico approaches. Male BALB/c mice were divided into two experimental cohorts, to identify
the best dose and to further assess the role of carveol in the nuclear factor E2-related factor;
nuclear factor erythroid 2; p45-related factor 2 (Nrf2) pathway. The results demonstrated that
carveol signiﬁcantly modulated the detrimental effects of APAP by boosting endogenous
antioxidant mechanisms, such as nuclear translocation of Nrf2 gene, a master regulator of the
downstream antioxidant machinery. Furthermore, an inhibitor of Nrf2, called all-trans retinoic
acid (ATRA), was used, which exaggerated APAP toxicity, in addition to abrogating the
protective effects of carveol; this effect was accompanied by overexpression of inﬂammatory
mediators and liver  2ltoxicity biomarkers. To further support our notion, we performed virtual
docking of carveol with Nrf2-keap1 target, and the resultant drug-protein interactions validated
the in vivo ﬁndings. Together, our ﬁndings suggest that carveol could activate the endogenous
master antioxidant Nrf2, which further regulates the expression of downstream antioxidants,
eventually ameliorating the APAP-induced inﬂammation and oxidative stress.
Keywords: acetaminophen, carveol, hepatotoxicity, anti-inﬂammatory, Nrf2 pathway

INTRODUCTION
Liver diseases are associated with an increased number of disability cases, and approximately 50
million liver-associated morbidity and mortality reports are documented each year (Gorrell, 2005).
Because of the persistent and continuous involvement of the liver in metabolic processes, the
accumulation of free radicals overwhelms the natural defense system, making the liver one of the
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susceptibility to oxidative stress and inﬂammatory damage.
Previous studies have demonstrated that Nrf2 plays a critical
role in the regulation of inﬂammation and oxidative stress, which
are linked to the pathophysiologies of several diseases. Therefore,
Nrf2 can be considered a potential pharmacological target to be
investigated against various insults, including APAP.
Natural drug moieties are an attractive source of new drugs,
owing to their rich antioxidant potential. Several natural drugs
have hepatoprotective potential against a variety of mediators,
including free radicals and inﬂammatory factors (James et al.,
2003; Lee et al., 2006). Carveol, a monoterpene phenol, is isolated
from the essential oils extracted from the plant family Lamiaceae
or Labiatae, which includes the genera Thymbra, Origanum,
Corydothymus, Satureja, and Thymus (Figure 1) (Pastore
et al., 2003). It has long been used in traditional Chinese
medicine as an antispasmodic, a carminative, and an
astringent (Aleksunes et al., 2008) and has been evaluated in
the treatment of indigestion and dyspepsia (Guo and White,
2016). Carveol has been demonstrated to have antioxidative,
antihyperlipidemic, and anti-inﬂammatory activities, and
ameliorate liver toxicity in a mouse model of carbon
tetrachloride (Patterson et al., 2013). However, to date, the
potential hepatoprotective effects of carveol against APAP
have not been evaluated. Taking into consideration the
pharmacological value of essential oils extracted from plant
sources and the signiﬁcance of new drug discovery, the
current study sought to investigate whether carveol mitigates
APAP-induced detrimental effects. If so, the potential underlying
molecular and cellular mechanisms should be further delineated
to explain the effects of carveol on hepatocellular protection. This
will not only expand the understanding of the molecular
cascading mechanism of cell death but will also provide some
clues to unveil the therapeutic potential of carveol.

Figure 1 | Chemical structure of (A) carveol and (B) paracetamol.

most vulnerable organ. These free radicals are the prominent
cause of oxidative stress-induced thiol depletion and lipid
peroxidation, which subsequently trigger toxic cascading
events and eventually lead to various hepatic pathologies, such
as cirrhosis and acute or chronic hepatitis (Abo-Haded et al.,
2017).
Paracetamol (acetaminophen, N-acetyl p-aminophenol, or
APAP) is a non-prescription drug with both analgesic and
antipyretic activities, and this drug is included in several
preparations, either as a single moiety or in combination
(Ghaffar and Tadvi, 2014). It has a large therapeutic window
and is generally safe; however, when abused in large doses, it leads
to severe hepatic necrosis and hepatic failure (Al-Fartosi et al.,
2011). Currently, paracetamol is considered the chief causative
agent of acute liver failure due to accidental overdose, which
requires a liver transplant in some extreme cases (Gopal et al.,
2011; Du et al., 2016). At a high dose, APAP is metabolized to
glucuronic acid or sulfate conjugates (Sharma et al., 2016) and is
transformed into the pro-reactive cytotoxic intermediate
N-acetyl-phenzoquinoneimine (NAPQI), which is responsible
for oxidative stress and intracellular glutathione (GSH)
depletion (Shah et al., 2014; Hellerbrand et al., 2017; Zai et al.,
2018). The covalent binding of NAPQI to mitochondria initiates
cascading pathological processes, such as free radical formation
and peroxynitrite accumulation, further supplemented by the
release of pro-inﬂammatory cytokines and mediators, all of which
collectively exacerbate acute and chronic liver necrosis
(Dalaklioglu et al., 2013; Hennig et al., 2018). Various
hepatoprotective strategies have been evaluated to protect the
liver from toxins. The current clinical practice recommends
silymarin as a hepatoprotective supplement to cope with
various liver insults, including APAP and methotrexate (MTX)
(Crowell et al., 1992). The transcription factor Nrf2 is an integral
part of the host cellular defense mechanism against oxidative
stress and electrophilic insult. Nrf2 binds to antioxidant response
elements (ARE) at the promoter site, which in turn encodes
several antioxidant/phase-II detoxifying enzymes and other
relevant stress-responding factors (Thompson Coon and Ernst,
2002). Previous studies have revealed the involvement of Nrf2ARE signaling in attenuating inﬂammation in several pathologies,
such as stroke, and other disorders (Ma and He, 2012; Ning et al.,
2018). Hence, dysregulation of Nrf2 signaling results in increased
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MATERIALS AND METHODS
Chemicals and Reagents
The pharmaceutical drugs (silymarin and N-acetyl para
aminophenol (paracetamol CAS: 103-90-2, C8H9NO2: APAP)
of HPLC grade (99%) were supplied by a local pharmaceutical
manufacturer and used as raw material. All the antibodies were
procured from Santa Cruz Biotechnology, United States, or
Abcam, United Kingdom. Phosphate-buffered saline (PBS)
tablets were used for all morphological analyses or fresh
buffers were prepared for each use. The details and
corresponding catalog numbers of the primary antibodies are
HO-1 (SC-13691), TRX (SC-20146), Nrf2 (SC-722), COX-2 (SC514489), p-JNK (SC-6254), TNF-α (SC-52B83), and p-NFκB
(SC-271908).
Other
immunohistochemistry-related
consumables, such as AB and C Elite kit (two vials-SC-2018)
and 3,3-diaminobenzidine (DAB) (SC-216567), were also
provided by Santa Cruz Biotechnology, United States. The
biotin secondary antibody (ab-6789) and DPX mounting
media were purchased from Abcam United Kingdom. The
p-NFκB enzyme-linked immunosorbent assay (ELISA) kit (Cat
# SU-B28069) and Nrf2 kit (cat. no. SU-B30429) were purchased
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Figure 2 | Experimental design 1 (A). Carveol, APAP, and silymarin were prepared in 0.9% NaCl, while ATRA was prepared in a mixture of 2% dimethyl sulfoxide
and 0.9% NaCl (n  10/group). Baseline reading was recorded at the beginning (0th day of the experiment), and mean weight and food intake were monitored during the
entire experiment (B) Diagrammatic illustration of in vivo study for the Nrf2 signaling pathway. The treatment protocol was continued for 3.5 days. In all these groups, a
single loading dose of paracetamol was injected (400 mg/kg, i. p.) 15 min after the last dose of ATRA or carveol or silymarin, except in the saline group. Serum
samples and liver tissues were collected after 6 h of the last dose.

from Shanghai Yuchun Biotechnology, China. HO-1 (cat. No.
E-EL-R0488), and TNF-α (E-EL-R0019) ELISA kits were
purchased from Elabscience.

euthanizing the mice if they displayed a severe sign of distress
or suffering. The mice were subjected to the following
experimental protocols. Two separate cohorts of animals were
used for the experiments as follows:

Animals and Drug Treatment
Experimental Cohort 1

Male BLAB/c mice, weighing 30–35 g and 8–10 weeks old, were
housed (three per cage) at the facility of the Riphah Institute of
Pharmaceutical Sciences (RIPS), under-documented protocols
(temperature: 22 ± 1 °C; humidity: 50 ± 10%). Strict laboratory
protocols were followed during all experimental procedures. The
animals were kept for some days at the facility before the
experimental procedures, and the body weights were
constantly checked every day throughout the study.
Furthermore, we strictly followed the approved protocols and
guidelines of the institutional research ethical committee (REC)
of the Riphah Institute of Pharmaceutical Sciences (RIPS),
Islamabad (Approval ID: Ref. No. REC/RIPS/2018-19/A202),
which are similar to the ARRIVE guidelines, with some minor
exemptions. We adopted the human endpoint criteria for
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The mice treatment protocol is indicated in Figure 2A, and the
following groups were employed. 1) Saline group: the mice received
saline (0.9% NaCl) injection intraperitoneally (i. p.) for seven
consecutive days, 2) APAP group: the mice received a single
dose of paracetamol orally/per os (400 mg/kg, p. o.) for 7 days,
3) Three different groups of APAP + carveol: the mice received
paracetamol orally for seven consecutive days, followed by a single
i. p. injection of different doses of carveol, namely APAP + carveol
5 mg (5 mg/kg, i. p.); APAP + carveol 10 mg (10 mg/kg, i. p.);
APAP + carveol 15 mg (15 mg/kg, i. p.), 4) APAP + silymarin
group: the mice received paracetamol orally for seven consecutive
days, followed by silymarin (50 mg/kg, i.p). Carveol, APAP, and
silymarin were prepared in 0.9% NaCl (n  14 per/group). At the
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end of the experiment, the mice were anesthetized with xylazine
and ketamine (i. p.); blood was collected via cardiac puncture and
was processed for biochemical analysis. Samples from the liver
were taken and frozen at −50 °C or preserved in 4%
paraformaldehyde for ELISA or parafﬁn sectioning, respectively.
Next, 4 μm thin hepatic tissue sections were made with a rotary
microtome from the parafﬁn block, for histological analysis.
Overall, three mice died during the experimental procedures,
two from APAP and one from the Carveol + APAP groups,
which we excluded from the experiment. The saline-treated
mice survived throughout the experiments.

the assay, the stock of 0.2 M sodium phosphate buffer was
prepared as Na2HPO4.2H2O and NaH2PO4 (pH 8). For
sample loading, buffer (153 μL), freshly prepared 1 mmol
DTNB (40 μL), and the supernatant (6.6 μL) were sequentially
mixed, and after 15 min, the absorbance of this mixture was
determined using a spectrophotometer at 412 nm. A mixture of
DTNB solution and phosphate buffer served as the control,
whereas the buffer was used as a blank. The absorbance was
calculated from the values of the absorbance of the control and
the sample and expressed as µmol/mg protein. To detect GST
activity (Imran et al., 2020), the stock of 0.1 M potassium
phosphate buffer was prepared as KHPO4 and KH2PO4 (at a
1:2 ratio, pH 6.5). For the assay, 1 mmol GST and 1 mmol CDNB
were also prepared; then GST solution, CDNB, potassium buffer,
and tissue homogenate were mixed (at a 1:1:27:1 ratio) and the
optical density was determined at 340 nm. The phosphate buffer
was used as a blank, and the assay mixture without homogenate
was used as a control. GST activity was calculated using the
extinction coefﬁcient of the product and expressed as nmoles of
CDNB conjugated/min/mg protein.

Experimental Cohort 2
The mice treatment protocol is indicated in Figure 2B, and the
following groups were employed with n  10/gp. 1) Saline group:
the mice received saline (i. p.), 2) APAP + ATRA group: the mice
received seven injections of ATRA (10 mg/kg, i. p.) at 12 h
intervals, 3) APAP + ATRA + Carveol group: the mice
received carveol 15 mg/kg i.p 4 h after each ATRA dose, and
4) APAP + ATRA + silymarin group: the mice received silymarin
50 mg/kg i.p 4 h after each ATRA dose. For all the groups except
saline, APAP 400 mg/kg was administered (i. p.) 15 min after the
last dose of ATRA (APAP + ATRA group) or carveol (APAP +
ATRA + carveol) or silymarin (APAP + ATRA + silymarin). At
the end of the treatment, the mice were sacriﬁced and samples
were collected.

Determination of Lipid Peroxidation (LPO) in
Tissue
Oxidative stress augmented the oxidation of macromolecules,
such as lipids, which can be quantiﬁed by the thiobarbituric acid
reactive substance (TBARS) levels. A previously reported
protocol was adopted for the LPO assay, with minor changes
(Imran et al., 2020). Approximately 40 µL of tissue supernatant
was added to a freshly prepared solution of ferric ammonium
sulfate and incubated for some time. Next, after the addition of
75 μL of thiobarbituric acid (TBA) to the mixture, the color
changed, and the absorbance of the resultant mixture was
immediately measured using a microplate reader (at 532 nm).
The levels were expressed as nmol Tbras/min/mg protein (Iqbal
et al., 2020).

Hematoxylin and Eosin (H and E) Staining
Hematoxylin and eosin staining was performed according to our
previous protocols (Ali et al., 2019; Ansari et al., 2019; Ullah et al.,
2020). Brieﬂy, the non-coated slides initially underwent a
deparafﬁnization step with xylene, followed by hydration
(graded ethanolic series), and ﬁnally with water. The slides
were incubated in a Coplin jar containing hematoxylin to stain
the nucleus. The slides were washed with water and traced for
nuclear staining, using a compound microscope. The slides were
then dipped in 1% HCl, 1% ammonia water, and rinsed with
water. Eosin staining was then performed, the slides were
subjected to dehydration, ﬁxed in xylene, and covered with
coverslips. Five images per slide were obtained using a light
microscope (Olympus, Japan) at the same threshold intensity,
and were later analyzed using ImageJ software to quantify the
number of distorted, vacuolated, inﬁltrated, and surviving cells.

Immunohistochemical Analysis
We used coated slides for immunohistochemical studies as
described in a previous study (Rana et al., 2020). The slides
were subjected to deparafﬁnization and hydration protocols as
discussed for H and E. To unlock the antigenic epitopes from
paraformaldehyde, proteinase K was applied to the tissue,
followed by PBS rinsing. After hydration, the slides were not
allowed to dry at any stage of the immunohistochemical analysis.
Before blocking with normal goat serum the slides were treated
with H2O2 to eradicate peroxidase activity. The selectivity of
serum depends upon the source of the secondary antibody. After
blocking for an appropriate time, primary antibodies, such as
nuclear factor-κB (p-NFκB), COX2, c-Jun N-terminal kinase
(p-JNK), HO-1, TNF-α, and Nrf2 (dilution 1:100, Santa Cruz
Biotechnology), were applied overnight in a moistened box in the
refrigerator. The following morning, the slides were removed and
kept for 1 h at room temperature in a moistened chamber. After
rinsing with PBS, the biotinylated secondary antibody (goat antimouse and goat anti-rabbit) was applied, followed by the
application of ABC reagent (SCBT United States) in a

Liver Functional Biomarkers
Enzymes, such as AST, ALT, phosphatases, and total bilirubin
(TB), were spectroscopically analyzed using an autoanalyzer
(Olympus AU-2700) according to the manufacturer’s
instructions.

Oxidative Enzyme Analysis and Lipid
Peroxidation
The non-enzymatic glutathione (GSH) level and the enzymatic
glutathione S-transferase (GST) activity were determined as
previously described (Ullah et al., 2020). After homogenizing
liver tissue samples (cohort 1), the supernatant was collected. For
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humidiﬁed chamber, and the slides were rinsed with PBS and
stained with DAB. The slides were then dried, dehydrated in
ascending ethanolic series, ﬁxed in xylene, and covered with
coverslips. The liver positive cells for all the primary
antibodies were quantiﬁed using the ImageJ software.

Enzyme-Linked Immunosorbent Assay
(ELISA)
p-NFκB, HO-1, Nrf2, and TNF-α levels were quantiﬁed using an
ELISA kit as per the manufacturer’s instructions (for detailed
chemicals and reagents). Approximately 50 mg of the tissue
sample was homogenized, using PBS (also containing PMSF as
a serine inhibitor), at 15,000 RPM, followed by centrifugation and
collection of the supernatant. Protein concentration in each
homogenate was calculated using the BCA kit (Thermo
Fisher), and the resultant protein concentration was added to
each well to determine the level of the respective proteins, using
an ELISA reader. The resultant picograms of cytokines per
milliliter (pg/ml) were then converted pg/mg total protein).

Real-Time Polymerase Chain Reaction
(RT-PCR)

Figure 3 | Effect of carveol treatment on physical parameters, such as
body weight and food intake. (A) Bodyweight changes (B) Mean food intake.
The number of animals was 14/group, and the results were analyzed using a
repeated two-way ANOVA test. ###p < 0.001, ##p < 0.01 compared to
the APAP group, ***p < 0.001, compared to the saline group.

Total RNA was extracted from the freshly isolated liver of mice in
experimental duplicates using the TRIzol method. 20 µL of
M-MuLV reverse transcriptase was used to dilute 1 μg of RNA
and used this mix to synthesize cDNA with a cDNA synthesis kit
(vivantis cDSK01-050 Sdn. Bhd, Malaysia). To estimate the gene
expression of Nrf2 quantitatively, real-time PCR was performed
using the 2X HOT SYBR Green qPCR master mix (Solar Bio cat #
SR1110) and real-time Mic PCR (BioMolecular System)
according to the manufacturer speciﬁcations. The sequence of
the primers used for ampliﬁcation was Nrf2 Forward: CCATTT
ACGGAGACCCACCGCCTG and Reverse: CTCGTGTGAGAT
GAGCCTCTAAGCGG and GAPDH, Forward: AGGTCGGTG
TGAACGGATTTG and Reverse: TGTAGACCATGTAGTTGA
GGTCA (Wakabayashi et al., 2014). The relative gene expressions
of Nrf2 was determined by the 2^−ΔΔCT method for real-time
quantitative PCR.

prepared and analyzed. The structure of carveol was collected
from online sources.

Statistical Analysis
The symbols p, #, $, and β were used to indicate a signiﬁcant
difference. * or β indicates differences compared to saline, while #
to APAP and $ represents a signiﬁcant difference to APAP +
ATRA. All the data are expressed as mean ± SEM, and ImageJ
software was used to analyze all the histological data (ImageJ 1.30;
https://imagej.nih.gov/ij/). Bodyweight and food intake data were
analyzed using a repeated two-way ANOVA, and the remaining
data were analyzed using one-way ANOVA with Tukey’s
multiple comparison test as a post-hoc test.

Bioinformatic Studies
In silico studies were performed as previously described (Shah
and Rashid, 2020). Brieﬂy, the 3-dimensional structures of
cyclooxygenase (COX2) PDB ID: IPXX, interleukin (IL-1β)
PDB ID: 2MIB, PDB ID: 2TNF for TNF-α, PDB ID: 3TTI for
JNK, PDB ID: ILE5 for nuclear factor-kB (NFκB), PDB ID: 1DVE
for HO-1, and PDB ID: 2LZ1 for Nrf2 were downloaded from the
RCSB protein data bank in Discovery Studio (DSV). Docking
studies require PDB and mol2 format, for which the 3D structure
of the proteins and ligand carveol were downloaded in the
respective format. Both protein and ligand were loaded into
the PyRx docking software, and drug-receptor interactions
were evaluated by binding the energy values (E-value). The
E-values further validated the best pose of the ligand in the
complex, and by DSV, the best orientation and interaction were

Frontiers in Pharmacology | www.frontiersin.org

RESULTS
Results of Experimental Design one
Effect of Carveol on Body Weight and Food Intake
Our results showed that APAP induced a dramatic and persistent
loss of body weight. However, carveol prevented body weight loss
in a dose-dependent manner (Figure 3A). Carveol, at 15 mg/kg
per day, showed the most signiﬁcant effect on body weight (p <
0.001). Bodyweight reduction could be attributed to decreased
food intake, as APAP-treated mice consumed signiﬁcantly less
amount of food; however, carveol ameliorated this effect in a
dose-dependent manner, which is comparable to that of silymarin
(50 mg/kg) (Figure 3B, p < 0.001).
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TABLE 1 | The protective effect of carveol on liver functional enzymes: APAP augmented the serum level of LFTs and attenuated high-density lipoprotein (HDL) level, while
carveol, with respect to APAP, mitigated LFT levels and increased HDL levels.
Treatment

ALT (U/L)

AST (U/L)

TP (g/dl)

TB (mg/dl)

ALP (U/L)

Albumin
(g/dl)

LDL (mg/dl)

HDL (mg/dl)

Saline
APAP
400 mg/kg
APAP +
Carveol
5 mg/kg
APAP +
Carveol
10 mg/kg
APAP +
Carveol
15 mg/kg
APAP +
Silymarin
50 mg/kg

59 ± 8.71
194.66 ± 6.02***

106 ± 13.89
276.66 ± 27.02***

7.8 ± 0.30
3.53 ± 0.40***

0.33 ± 0.18
2.16 ± 0.30***

98.66 ± 15.53
220.33 ± 49.44***

4.93 ± 0.65
2.23 ± 0.30***

39 ± 5.56
102.66 ± 13.05***

78.66 ± 8.02
37.66 ± 2.51***

164.66 ± 10.69

269.33 ± 81.5

5.7 ± 0.45##

1.23 ± .37##

177 ± 11.78

3.5 ± 36

78.66 ± 17.4

41.66 ± 3.05

148.33 ± 11.37#

258.66 ± 36.67

5.53 ± 1.19##

1.03 ± .20##

136.66 ± 3.05##

4.23 ± .41#

64 ± 21#

52.66 ± 6.5#

95.33 ± 7.37###

172.33 ± 14.7##

6.6 ± 0.55###

0.525 ± 0.03###

122.66 ± 8.50###

4.5 ± 0.36##

65.66 ± 17.67##

64.66 ± 7.76##

81.33 ± 8.50###

138.66 ± 14.22##

6.16 ± 0.40###

0.67 ± 0.29###

130 ± 16.70###

5.93 ± 0.85##

51.33 ± 9.29##

52.33 ± 2.08#

The data are presented as means ± SEM and were analyzed using one-way ANOVA with n  7/group. The symbols ppp and ### represent p < 0.001 and the symbol ## represents
p < 0.01 values of signiﬁcant differences. The samples were processed from cohort 1.

TABLE 2 | Effect of carveol on oxidative enzymes.
Treatment

GSH (μmol/mg protein)

GST (nmoles of CDNS
conjugated/min/mg protein)

TBARS (nmoles Tbras/min/mg
protien)

74.88 ± 13.78
6.30 ± 4.97***
44.4 ± 9.26#
54.49 ± 9.98##
62.29 ± 18.82###
66.68 ± 11.45###

25.42 ± 1.30
1.78 ± 1.50***
4.67 ± 0.91
8.83 ± 1.62#
14.2 ± 1.43##
18.20 ± 2.31##

79.32 ± 0.70
215.58 ± 5.82***
192.54 ± 2.80
167.78 ± 2.164#
131.74 ± 0.64##
115.83 ± 2.164##

Saline
APAP 400 mg/kg
APA + Carveol 5 mg/kg
APA + Carveol 10 mg/kg
APA + Carveol 15 mg/kg
APAP + Silymarin 50 mg/kg

The symbols ppp and ### represent p < 0.001, while the symbol ## or # represents p < 0.01 and p < 0.05, n  7/group. The data are expressed as mean ± SEM and were analyzed using
one-way ANOVA followed by Tukey’s multiple comparison test. The samples were processed from cohort 1.

Carveol Improved the Liver Detriments of APAP
Table 1 shows that APAP signiﬁcantly disturbed the
functional markers (p < 0.001), while carveol at different
doses normalized the values in the APAP-administered
group; carveol at 15 mg exhibited similar effects as those of
silymarin.

Effects of Carveol on Antioxidant Enzymes
Table 2 summarizes the effects of carveol on changes in
endogenous enzyme activities, following APAP treatment.
APAP stimulated GSH depletion (6.30 ± 4.97), and
antioxidant enzyme glutathione-S-transferase (GST) (1.78 ±
1.50) in the hepatic tissue (p < 0.001). Treatment with carveol
at different doses attenuated the downregulation of GSH (62.29 ±
8.82) and GST (14.2 ± 1.43).

Carveol Alleviated the Liver Metabolic Deﬁcits
Induced by APAP
The liver plays a principal role in the synthesis, storage, secretion,
and catabolism of proteins, bilirubin, lipoproteins, and lipids,
which represent sensitive markers during liver damage. Our
results showed a signiﬁcant increase in the levels of total
protein (TP), albumin, and HDL, accompanied by decreased
total bilirubin (TB) and low-density lipoprotein levels
(Table 1). These results suggest that liver anabolic and
catabolic functions were both severely hampered. Moreover,
carveol showed a dose-dependent protective effect, which was
comparable to the effects of silymarin at a dose of 15 mg/kg.
Furthermore, the effect of carveol on HDL levels was more
signiﬁcant (p < 0.01) than that of the silymarin-treated group
(p < 0.05).
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Effect of Carveol on LPO
The LPO content in the liver homogenate of the APAP group was
increased to 215.58 ± 5.82, compared to that in the saline group
(p < 0.001, Table 2). Carveol at 15 mg/kg dose signiﬁcantly (p <
0.01, Table 2) attenuated this content (131.74 ± 0.64), an effect
that could be matched to that of the silymarin group.
Carveol Protected the Liver From APAP-Induced
Cellular Damage
The results of H and E staining revealed signiﬁcant
histopathological changes in the APAP-intoxicated animals
(Figure 4, ###p < 0.001). Signiﬁcant alterations were observed
in the APAP group, compared to those in the saline-treated
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Figure 4 | Carveol restored the morphological integrity of the liver, as shown by histological examination. Liver tissue was stained with H and E (magniﬁcation, ×10
scale bar 75 μm and 40× scale bar 20 µm). The data are presented as means ± SEM and were analyzed using one-way ANOVA followed by Tukey’s multiple comparison
test; n  7/group. The symbols ppp and ### represent signiﬁcant difference values of p < 0.001, and ## or # represent signiﬁcant difference values of p < 0.01 or p < 0.05
respectively. The slides were processed from cohort 1.

TABLE 3 | Effect of carveol on histopathological scoring.
Groups

Saline
APAP 400 mg/kg
APA + Carveol 5 mg/kg
APA + Carveol 10 mg/kg
APA + Carveol 15 mg/kg
APAP + Silymarin 50 mg/kg

Hepatocytes necrosis

Inﬂammatory
cells inﬁltration

Fatty degeneration/vacuolization

—
+++
+++
+
—
—

—
+++
++
+
—
—

—
+++
++
+
±
±

+++ signiﬁcant, ++ high, + moderate, —nil.

animals. The saline group showed normal hepatic cell shape, and
there was no vacuolization or lipid globule. Nevertheless, many
aberrant morphological features, such as sinusoidal dilatation,
hepatocyte degeneration with loss of lobular architecture/
hepatocyte disarray, pericentral lymphocytic inﬁltration,
moderate steatosis/fatty degeneration, and abundant
inﬂammatory cell inﬁltration, were observed in the APAPtreated groups (Table 3). Carveol treatment signiﬁcantly
reversed these histopathological abnormalities induced by
APAP, in a dose-dependent manner, as revealed by the
microscopic scores (Carveol histopathological score).

expression of these mediators in the APAP-administered
group (p < 0.001) (Figures 5A,B), whereas carveol dose at
15 mg signiﬁcantly reduced their hyperexpression (p < 0.01,
Figure 5A, p < 0.001, Figure 5B). Moreover, COX-2 and
p-NFκB expression were also evaluated, and the results
showed that both were highly expressed in the APAP group
(p < 0.001, Figures 5C,D). Carveol attenuated the expression of
p-NFκB and TNF-α in a dose-dependent manner.

Effect of Carveol on the Nrf2 Signaling Pathway
To examine the possible effect of carveol on the Nrf2 signaling
pathway, the expression of Nrf2, HO-1, and TRX was determined
via immunohistochemistry (Figure 6). APAP activated the
expression of Nrf2 (Figure 6A) and TRX (p < 0.05,
Figure 6C) due to oxidative stress, and carveol, at 15 mg/kg,
further expressed these antioxidative proteins to counteract
oxidative stress (p < 0.001, Figure 6A, p < 0.01, Figure 6C).
HO-1 and thioredoxin TRX exhibit similar characteristics, as
both are antioxidants and eradicate reactive oxygen species,
thereby protecting the cell from inﬂammation and apoptosis
(Shah et al., 2018; Li and Liu, 2019). The effect of carveol on
the thioredoxin protein level was evaluated in different

Effect of Carveol on APAP-Mediated Inﬂammatory
Markers
The JNK signaling pathway mediates the stress-induced
inﬂammatory cascade and is implicated in mitochondrial
apoptosis, and its activation results in the phosphorylation of
numerous transcription factors, such as AP-1, p53, Bax, and
Bim. Furthermore, JNK can trigger other mediators, such as
TNF-α, p-NFκB, and COX-2 (Ali A et al., 2020). To reveal the
possible involvement of JNK and TNF-α, immunohistochemical
staining was performed, and the results showed higher
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Figure 5 | Effect of carveol on inﬂammatory mediators. The presented images indicate immunoreactivity of (A) p-JNK (B) TNF-α (C) COX-2, and (D) p-NFκB. Scale
bar  25 μm, magniﬁcation ×40 with n  7/group. The data presented are relative to saline and the number of experiments performed  3. The data are presented as
means ± SEM and were analyzed using one-way ANOVA followed by Tukey’s multiple comparison test. The symbols ppp and ### represent signiﬁcant difference values
of p < 0.001, while the symbol ## represent p < 0.01 values for signiﬁcant differences and # represents p < 0.05. The slides were processed from cohort 1.

Frontiers in Pharmacology | www.frontiersin.org

8

January 2021 | Volume 11 | Article 621538

Rahman et al.

Hepatoprotective Effects of Carveol in APAP Model

Figure 6 | Effect of carveol on immunohistochemistry expression (A) Nrf2 (B) HO-1, and (C) TRX with magniﬁcation ×40, and scale bar  25 μm, n  7/group.
Representative histograms indicate a comparatively lower expression of (A) Nrf2 (B) HO-1, and (C) TRX in the APAP group than the carveol group. The data are
presented as means ± SEM and were analyzed using one-way ANOVA followed by Tukey’s multiple comparison test. The symbols ### represent signiﬁcant difference
values of p < 0.001, while the symbol ## represents p < 0.01 values of signiﬁcant differences, and p or # represents p < 0.05. # is signiﬁcantly different from APAP.

experimental groups. Representative images and densitometric
analysis are shown in Figure 6.

performed ELISA and we demonstrated similar results for Nrf2
(Figure 7B). The level of HO-1 was also decreased by ATRA (p <
0.001). Treatment with carveol at 15 mg/kg modulated the level of
Nrf2 and HO-1, whereas ATRA treatment blocked the effects of
carveol on Nrf2 (p < 0.05, Figures 7B,C). The expression of
p-NFκB and TNF-α was also evaluated in these groups, and the
results coincided with the Nrf2 ﬁndings, with hyperexpression in
the ATRA + APAP group (p < 0.001). Moreover, carveol
(15 mg/kg) attenuated the expression of p-NFκB and TNF-α
in the carveol + ATRA + APAP group (p < 0.05, Figure 7D,
p < 0.001, Figure 7E). The results were further validated using
biochemical analysis (Tables 4) and H and E staining (Figure 8),

Results of Experimental Design 2
Carveol Enhances the Antioxidant Capacity of the
Liver via the Nrf2 Signaling Pathway
To further investigate whether the antioxidative effects of carveol
against APAP-induced liver injury, in vivo, are Nrf2-dependent,
we blocked the Nrf2 effect by using ATRA at a dose of 10 mg/kg.
As shown in Figure 7A, Nrf2 gene expression was elevated by
carveol at 15 mg dose, while ATRA downregulated this
expression. To further validate the hepatoprotective effect, we
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Figure 7 | Carveol produces Nrf2-dependent effects. (A) qPCR analysis, (B) Nrf2 (C) HO-1, (D) p-NFκB, and (E) TNF-α were quantiﬁed using ELISA. The data are
expressed as mean ± SEM and were analyzed using one-way ANOVA followed by Tukey’s multiple comparison test, and n  5/group. The symbols ppp, βββ and
represent signiﬁcant difference values of p < 0.001, while the symbol $ represents signiﬁcant difference values of p < 0.05. The symbol p or β represents a signiﬁcant
difference relative to saline, while $ represents a signiﬁcant difference relative to the APAP + ATRA group. The samples were collected 6 h later, for biochemical and
morphological analyses. The samples were processed from cohort 2.

TABLE 4 | ATRA abrogated the effects of carveol.
Treatment
Saline
APAP 400 mg/kg + ATRA 10 mg/kg
APAP + ATRA + Carveol 15 mg/kg
APAP + ATRA + Silymarin 50 mg/kg

ALT (U/L)

AST (U/L)

TP (g/dl)

ALP (U/L)

LDH (mg/dl)

67 ± 5.4
456 ± 13.25βββ
219 ± 12.56$$$
183 ± 14.23$$$

89 ± 5.32
634 ± 16.35βββ
376 ± 3.45$$$
312 ± 8.64$$$

6.8 ± 1.56
2.6 ± 1.7ββ
5.3 ± 1.21$$
5.8 ± 2.1$$

110 ± 2.7
545 ± 9.89βββ
278 ± 7.89$$$
267 ± 5.78$$$

441.33 ± 14.46
3653 ± 4.03βββ
2162 ± 21.72$$
2017.66 ± 25.91$$

ATRA augmented the serum level of LFTs and attenuated the TP, while carveol signiﬁcantly reduced LFT levels compared to those in the ATRA + APAP group, and increased the total
protein level. The symbols βββ and $$$ represent signiﬁcant difference values of p < 0.001, while the symbol $$ represents p < 0.01 values of signiﬁcant differences, the symbol $
represents a signiﬁcant difference relative to APAP + ATRA, while β represents a signiﬁcant difference relative to the saline group. The data are expressed as means ± SEM and were
analyzed using one-way ANOVA followed by Tukey’s multiple comparison test, n  5. The samples were processed from cohort 2.
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Figure 8 | Histological examination and morphological changes in liver tissues. Liver tissues stained with H and E (magniﬁcation ×10 and 40×) (n  5/group). The
necrotic cells are marked and shown by an arrow; abundant inﬂammatory cell inﬁltration can be seen in the APAP + ATRA group. The data are presented as means ±
SEM and were analyzed using one-way ANOVA followed by Tukey’s multiple comparison test. The symbols βββ and $$$ represent signiﬁcant difference values of
p < 0.001, the symbol β shows a signiﬁcant difference relative to the saline, and the symbol $ shows a signiﬁcant difference relative to the APAP + ATRA group. The
slides were processed from cohort 2.

TABLE 5 | Binding energy values.
Groups

Saline
APAP 400 mg/kg + ATRA 10 mg/kg
APAP + ATRA + Carveol 15 mg/kg
APAP + ATRA + Silymarin 50 mg/kg

Hepatocytes necrosis

Inﬂammatory
cells inﬁltration

Fatty degeneration/vacuolization

—
+++
—
—

—
+++
—
—

—
++
—
—

LEU, Leucine; ASP, Aspartate; ARG, Arginine; GLY, Glycine; GLU, Glutamic acid.

DISCUSSION

with amassing of inﬂammatory cell migration observed in the
APAP + ATRA group (p < 0.001, Supplementary Image S1).

The clinical syndrome of a higher dose of APAP has long been
established, and the potent natural antioxidant carveol attenuates
APAP-induced detrimental outcomes in hepatic tissue; thus, this
study further attested to our previously published data. We
previously demonstrated that carveol treatment attenuated
ischemic stroke-induced neurodegeneration, by positively
affecting the Nrf2 pathway, thereby leading to a reduced
infarction area (Malik et al., 2020). We demonstrated here that
carveol reversed the oxidative and inﬂammatory cascades of
APAP, possibly by triggering the Nrf2-dependent antioxidative
mechanism, which is cross-linked to the pro-survival pathways
(Figure 10). Moreover, the low energy values and relatively higher
hydrogen bond formation further enhanced complex stability, as
revealed through the molecular docking analysis. Additionally,
previous studies have reported that targeting inﬂammation and
oxidative stress-coupled targets could provide better therapeutic
outcomes (Ali T et al., 2020; Ling et al., 2020), which opens several
avenues for the use of natural drug substances.
Paracetamol is an established inducer of liver toxicity in
laboratory animals, but the exact pathological mechanism for
this toxicity is not well known, and several mechanisms have been

Docking Studies
Comprehensive docking studies were conducted to explore the
possible targets of carveol. Cis-carveol was docked in the active
catalytic pocket of COX-2, HO-1, IL-1, NFκB, inducible nitric
oxide (iNOS), Nrf2, and TNF-α. Table 5 shows the binding
energies after docking analysis, and Figure 9 shows the best pose
of cis-carveol ﬁtting to COX-2, HO-1, IL-1, NFκB, iNOS, Nrf2,
and TNF-α after docking studies. The active sites of these
proteins were retrieved from the literature. It was perceived
that the hydroxyl group (OH-) of carveol participated in
hydrogen bond formation with a protein molecule
(Figure 9). The OH- groups of carveol, in these interactions,
acted as hydrogen bond donors and the respective protein
molecules were hydrogen bond acceptors. ASP-140 and
ARG-136 of HO-1, LEU-80, and THR-79 of IL-1β, GLY 61
of NFκB, LEU-365 of Nrf2, and GLU-115 of TNF-α were
involved in hydrogen bond interactions. In addition, noncovalent alkyl and Pi-alkyl interactions were observed, which
are crucial for temporary interactions, speciﬁcally for the drug
activity to be proﬁcient in a system.
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Figure 9 | Computational and docking analyses; (A) Tertiary structures of the proteins Nrf2, HO-1, NFκB, JNK3, COX-2, TNF-α, and IL-1β. (B) The docking results
show the best pose of carveol that ﬁtted to Nrf2, HO-1, NFκB, JNK3, COX-2, TNF-α, and IL-1β. The post-docking analysis was visualized using DSV in both 2D and 3D
poses. The interaction between carveol and Nrf2 is shown in the panels (A, B), HO-1 in the panels (C, D), NFκB in the panels (E, F), JNK in panels (G, H), COX-2 in the
panels (I, J), IL-1 in the panels (K, L), and TNF-α in the panels (M, N). The 3D poses are shown in the panels (A, C, E, G, I, K, M) and the 2D in the panels (B, D, F, H,
J, L, N). Abbreviations: iNOS, inducible nitric oxide; TNF-α, tumor necrosis factor; IL-1β, interleukin; HO-1, heme oxygenase 1, COX-2, cyclooxygenase.

proposed. NAPQI, which is a highly reactive metabolite, is mostly
attributed to this effect owing to its electrophilic nature, and it
attacks several macromolecular targets (Shah et al., 2014; Sharma
et al., 2016; Hellerbrand et al., 2017). The reactivity of NAPQI can
be abolished by endogenous antioxidant enzymes, such as
glutathione (James et al., 2003; Pastore et al., 2003; Lee et al.,
2006). We observed a dose-dependent effect. Interestingly,
carveol, at both doses, attenuated AST, ALT, and lactate
dehydrogenase, along with favorable histological ﬁndings.
We have shown here that carveol treatment stimulates Nrf2, a
key protein that combats various reactive oxygen species and other
stress kinases, thereby halting necrotic and apoptotic cell death in
the liver. The implications of inﬂammation, oxidative stress, and
antioxidative mechanisms have been established previously. Our
protein analysis using ELISA demonstrated that carveol alleviated
the expression of different inﬂammatory mediators and cytokines,
such as TNF-α and NFκB, which is further linked to increasing
Nrf2 nuclear translocation and activation of the antioxidant
machinery. Furthermore, such cascading events diminished the
release of pro-inﬂammatory mediators and cytokines, by
downregulating the NFκB signaling pathway, similar to
previously reported data (Ali A et al., 2020). Nrf2 played a
pivotal role in our model, as it reciprocally modulated the
oxidative stress-induced inﬂammation. This notion was further
demonstrated when ATRA treatment wore off the
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hepatoprotective effects of carveol and elevated the expression
of the inﬂammatory markers. These results are consistent with
other experimental models, in which Nrf2 shields against
inﬂammation (Mohsin Alvi et al., 2020). Thus, its activation,
either pharmacological or signaling cascades, rescues the tissue
from the hallmarks of inﬂammation and oxidative stress, while its
pharmacological inactivation deteriorates the pathological
conditions in several other related degenerative models.
Furthermore, the downstream targets of Nrf2, such as HO-1
and TRX, later mediated the protective mechanism of Nrf2. It
is worth mentioning here that natural drugs are frequently
reported to activate the cleavage of Nrf2-Keap1 dimer and thus
allow the translocation of Nrf2 to the nucleus, to stimulate
antioxidant machinery, including HO-1 and NAPDH quinine
dehydrogenase-1 (NQO1), and thus provide a notable
antioxidative mechanism to reverse the oxidative stress-induced
inﬂammation (Jaiswal, 2004).
GSH, SOD, and CAT are among the ﬁrst-line defense
antioxidants that are important and indispensable in the
defense of oxidants, particularly in the liver. SOD catalyzes the
conversion of superoxide free radicals to H2O2 and O2, while
CAT helps in protecting against the harmful effects of superoxide
and lipid peroxidation in the liver. Our results demonstrated that
carveol signiﬁcantly attenuated hepatic MDA, a biomarker of
lipid peroxidation, and leveled the GSH, SOD, and CAT contents,
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Figure 10 | The graphical representation indicates and elaborates the underlying antioxidant and anti-inﬂammatory mechanisms of carveol against the APAPinduced liver toxicity.

indicating a strong and complex effect of carveol in alleviating the
APAP-induced oxidative stress. GSH activity is vital both for
sustaining cellular homeostasis and for eliminating free radicals,
such as superoxide. Furthermore, consistent studies have
reported the detoxifying effect of GSH against electrophiles,
such as NAPQI (Zai et al., 2018). Moreover, several protective
agents act against liver insults, by normalizing GSH content.
Thus, increased GSH, SOD, and CAT biosyntheses could account
for the underlying mechanism of carveol against the NAPQIinduced oxidative stress and inﬂammation.
The Nrf2 pathway has a prominent protective role in the liver,
while APAP exerts a detrimental effect on the Nrf2 pathway. A
higher level of toxicity was observed in Nrf2-null mice than in
wild-type mice when exposed to hepatotoxic agents (Aleksunes
et al., 2008; Patterson et al., 2013; Guo and White, 2016). Previous
studies on traditional Chinese drugs have shown their ability to
activate Nrf2 and protect against the APAP-induced liver injury
in mice. Consistent literature suggests that activation of the
antioxidant machinery, such as Nrf2, could downregulate
oxidative stress and the inﬂammatory cascade machinery, such
as the NFκB pathway and cytokines (TNF-α and COX-2) (Ali A
et al., 2020). The critical role of carveol in mediating the
antioxidative effect of Nrf2 was further validated with the Nrf2
antagonist ATRA (Mohsin Alvi et al., 2020). ATRA
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administration removed the hepatoprotective effect of carveol,
abolished the increased levels of Nrf2 and HO-1, and further
exaggerated p-NFκB and TNF-α levels.
Several studies have documented the cross-talk between
oxidative stress and the inﬂammation process (Al Kury et al.,
2019; Al Kury et al., 2020). Therefore, drug therapeutics should be
designed to subside the inﬂammatory process and oxidative
distress, by triggering the endogenous antioxidant defense
system. We also studied the expression proﬁle of a thiolrelated protein, thioredoxin (TRX), an integral enzyme in
hemostatic redox reactions (Patterson et al., 2013). Carveol
treatment boosted the TRX level, which further validated the
antioxidant nature of carveol in APAP-induced liver injury.
However, the exact mechanism of how carveol abrogated liver
injury needs to be explored in detail.
APAP provokes free radical formation and subsequent proinﬂammatory mediators. Moreover, role of the JNK pathway in
inﬂammatory cascades and cellular death has been strongly
established (Ali A et al., 2020), and ROS and inﬂammatory
cytokines can trigger JNK activation (Ali A et al., 2020; Ali T
et al., 2020; Ling et al., 2020). Furthermore, the p-JNK pathway
has been implicated in various animal models and human
diseases (Shah et al., 2018; Li and Liu, 2019; Ali A et al., 2020;
Ling et al., 2020; Malik et al., 2020), and the downregulation or
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inhibition of this pathway has been found to contribute to the
protective strategy (Shah et al., 2019). We observed similar
activities in the APAP-intoxicated group, and carveol
signiﬁcantly reduced p-JNK expression. Furthermore, hepatic
necrosis can be attenuated by downregulating p-NFκB
expression, which may further act on the downstream COX-2
and iNOS and thus reduce ROS generation. Moreover, the
expression of COX-2 and iNOS can be prevented by
antagonizing p-NFκB expression (Ali A et al., 2020). Natural
drug substances have signiﬁcant anti-inﬂammatory potential, and
we previously showed the inhibitory effect of carveol, polydatin,
and Ginkgo biloba on NFkB, COX-2, and iNOS expression in
different experimental models (Al Kury et al., 2019; Al Kury et al.,
2020; Malik et al., 2020). We postulated here that carveol reduces
hepatocellular necrosis by negatively modulating the expression
of mitogen kinase and other inﬂammatory cytokines.
We performed docking analysis using the Autodock Vina
program. The binding energy was evaluated for carveol and
the respective proteins (Figure 9; Table 5). Different
intermolecular interactive forces are vital for energetically
stabilizing the drug-receptor complex. Carveol is ﬂexibly
complexed with protein targets, by establishing H-bonds and
other hydrophobic interactions. Hydrogen bond formation is
important for stabilization, recognition, and molecular
movement (Baker and Hubbard, 1984; Desiraju and Steiner,
2001). Several studies have revealed the importance of this
kind of bonding in ligand-protein complex stability, at a bond
distance of 2.6Ao–3.2Ao (Glusker, 1995; Sarkhel and Desiraju,
2004; Panigrahi and Desiraju, 2007). We speculate that the
formation of H-bonds between the ligand carveol and the
respective protein supports the corresponding complex stability.

and other neuroinﬂammatory mediators; it may, thus, offer a new
therapeutic option for preventing and managing oxidative stress
and inﬂammation in degenerative disorders.
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CONCLUSION
In summary, our in vivo results demonstrate that carveol could be
a potent antioxidant and anti-inﬂammatory agent that mediates
protective properties in APAP-induced liver toxicity.
Furthermore, our proposed mechanism suggests that carveol
may activate the master endogenous antioxidant protein Nrf2
and may be associated with the negative modulation of p-JNK
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